Press Releases Year None201920182017 November 18, 2019 Prevail Therapeutics Announces Appointment of Morgan Sheng, Ph.D., to Board of Directors November 12, 2019 Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights November 6, 2019 Prevail Therapeutics to Participate in Upcoming November Conferences October 8, 2019 Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases October 1, 2019 Prevail Therapeutics to Present at Upcoming October Conferences September 19, 2019 Prevail Therapeutics Announces Addition to Russell 2000®, 3000® and Microcap® Indexes September 10, 2019 Prevail Therapeutics Provides Program Update on PR001 in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease September 4, 2019 Prevail Therapeutics to Present at Morgan Stanley 2019 Global Healthcare Conference August 14, 2019 Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights August 7, 2019 Prevail Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 15
